• Centers and Departments
• Back to Cancer Center
• Our Specialty Programs
• AIDS Malignancy Treatment and Research Program
• Brain Tumor Program
• BreastCare Center
• Cancer Genetics and Prevention Program
• Colon and Rectal Cancer Program
• Gastrointestinal & Hepatobiliary Program
• Genitourinary Oncology Program
• Gynecologic Oncology Program
• Hematology Oncology
• Kidney Tumor Program
• Liver Tumor Program
• Pancreatic Cancer Program
• Prostate Cancer Center
  • About the Prostate Care Program
  • Meet Our Team
  • Understanding Prostate Cancer
  • Diagnosing Prostate Cancer
  • Prostate Cancer Therapies
  • Quality of Life
  • Prostate Cancer Center in the News
  • Learn More about Prostate Cancer
  • Patient Testimonials
  • Patient Instructions
  • EPICCP
• Sarcoma Program
• Skin/Cutaneous Oncology Program
• Thoracic Oncology Program

EPICCP

EPIC-CP: Expanded Prostate Cancer Index Composite for Clinical Practice

As survivorship after prostate cancer (PCa) diagnosis continues to improve with advances in detection and treatment, the effects of PCa treatment on health-related quality of life (HRQOL) are becoming increasingly important. The changes in HRQOL for each PCa treatment modality are well-recognized, but objective characterization and quantification of such changes are challenging. A validated tool that would be practical for use in both community and academic clinical practices, for use specifically in patients with prostate cancer has not yet been realized. Hence, we set out to develop and validate a shorter and more accessible HRQOL instrument designed specifically for use in the routine clinical care of prostate cancer patients.

Download the EPIC-CP instrument using the link below:

EPIC-CP